✦ LIBER ✦

Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma

✍ Scribed by Rena Morita; Satoshi Hashino; Shinichi Shirai; Noriaki Fujita; Masahiro Onozawa; Kaoru Kahata; Takeshi Kondo; Masahiro Imamura; Masahiro Asaka

Publisher: Carden Jennings Publishing
Year: 2008
Tongue: English
Weight: 202 KB
Volume: 88
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-008-0140-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ischemic heart disease associated with b

Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma

✍ Hiroyuki Takamatsu; Takeshi Yamashita; Takeharu Kotani; Aiko Sawazaki; Hirokazu 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 275 KB

Scleromyxedema and dermato–neuro syndrom

Scleromyxedema and dermato–neuro syndrome in a patient with multiple myeloma effectively treated with dexamethasone and bortezomib

✍ Nicole M. Fett; Mary B. Toporcer; Josep Dalmau; Michi M. Shinohara; Dan T. Vogl 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 2 views

Bortezomib in combination with thalidomi

Bortezomib in combination with thalidomide and dexamethasone—a successful treatment regimen in refractory extramedullary multiple myeloma

✍ Dominik Dytfeld; Magdalena Matuszak; Krzysztof Lewandowski; Mieczysław Komarnick 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 84 KB

Bortezomib in combination with dexametha

Bortezomib in combination with dexamethasone for a young multiple myeloma with t(8; 14)

✍ Jian-yong Li; Li-xia Wang; Wen-yi Shen; Shi-feng Lu; Li-juan Chen; Hua Lu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Bortezomib and dexamethasone for Japanes

Bortezomib and dexamethasone for Japanese patients with relapsed and refractory multiple myeloma: a single center experience

✍ Natsue Igarashi; Takaaki Chou; Takayuki Hirose; Yousuke Imai; Takuro Ishiguro 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 276 KB

Bortezomib, thalidomide, and dexamethaso

Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma : A retrospective study

✍ Jonathan L. Kaufman; Ajay Nooka; Mark Vrana; Charise Gleason; L. Thompson Heffne 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract ## BACKGROUND: This single‐center retrospective study determined the efficacy of bortezomib, thalidomide, and dexamethasone (BTD) as induction for patients with multiple myeloma (MM) who were eligible for autologous stem cell transplantation (ASCT). ## METHODS: Patients with symptoma